Bisogno G, Sparber-Sauer M, Rodeberg D, Merks JHM, Koscielniak E, Wolden SL, De Salvo GL, Del Bianco P, Xue W, Ebinger M, Vokuhl C, Venkatramani R, Volchenboum SL, Furner B, Minard Colin V, Hawkins DS. The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma data. Cancer. 2025 Jul 15;131(14):e35974. doi: 10.1002/cncr.35974. PMID: 40632016; PMCID: PMC12239856.
Study ID Citation
Abstract
The International Soft Tissue Sarcoma Consortium (INSTRuCT) was established in 2017 to enhance international collaboration. This study describes the characteristics of rhabdomyosarcoma (RMS) patients in the INSTRuCT database and examines differences across contributing groups. INSTRuCT includes data Children’s Oncology Group (COG), Cooperative Weichteilsarkom Studiengruppe (CWS), and European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) along with prior studies from Malignant Mesenchymal Tumour Committee (MMT) and Italian Soft Tissue Sarcoma Committee (STSC). Data standardization was supported by the University of Chicago’s Pediatric Cancer Data Commons. Pseudonymized patient‐level data from clinical trials were harmonized. Differences across groups were assessed using χ2 or Kruskal–Wallis tests.